Lori J Wirth (Lori Wirth)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Locally Advanced

Papillary Thyroid

Top Venues

Endocrine-related cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Thyroid : official journal of the American Thyroid Association

This page only lists publications with an associated author ORCID identifier.

Publications

Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, Martin Schlumberger
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocrine-related cancer 31 (8) (2024)
Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis, Bhavana Konda, Ramona Dadu, Eric J Sherman, Shaylene McCue, Nathan R Foster, Yuri E Nikiforov, Ticiana Della Justina Farias, Paul J Norman, Lori J Wirth
Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, Martin Schlumberger
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocrine-related cancer 31 (8) (2024)
Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, Martin Schlumberger
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocrine-related cancer 31 (8) (2024)
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis, Bhavana Konda, Ramona Dadu, Eric J Sherman, Shaylene McCue, Nathan R Foster, Yuri E Nikiforov, Ticiana Della Justina Farias, Paul J Norman, Lori J Wirth
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, Martin Schlumberger
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocrine-related cancer 31 (8) (2024)
Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, Martin Schlumberger
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocrine-related cancer 31 (8) (2024)
Mark F Sabbagh, Tyler Janovitz, Dora Dias-Santagata, Stephanie Siegmund, Valentina Nardi, Lori J Wirth, Gregory W Randolph, Jochen K Lennerz, Brennan Decker, Vania Nose, Bayan A Alzumaili, William C Faquin Md PhD, Justine A Barletta, Long P Le, A John Iafrate, Peter M Sadow, Adam S Fisch
FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy. Thyroid : official journal of the American Thyroid Association (2024)
Raj K Gopal, Venkata R Vantaku, Apekshya Panda, Bryn Reimer, Sneha Rath, Tsz-Leung To, Adam S Fisch, Murat Cetinbas, Maia Livneh, Michael J Calcaterra, Benjamin J Gigliotti, Kerry A Pierce, Andrew T Chan, Dora Dias-Santagata, Peter M Sadow, Lori J Wirth, Gilbert H Daniels, Ruslan I Sadreyev, Sarah E Calvo, Sareh Parangi, Vamsi K Mootha
Effectors enabling adaptation to mitochondrial complex I loss in Hurthle cell carcinoma. Cancer discovery (2023)
Naomi Kiyota, Makoto Tahara, Bruce Robinson, Martin Schlumberger, Steven I Sherman, Sophie Leboulleux, Eun Kyung Lee, Takuya Suzuki, Min Ren, Kazuma Fushimi, Lori J Wirth
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial. Cancer 128 (12) (2022)
Lori J Wirth, Cosimo Durante, Duncan J Topliss, Eric Winquist, Eyal Robenshtok, Hiroyuki Iwasaki, Markus Luster, Rossella Elisei, Sophie Leboulleux, Makato Tahara
Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit. The oncologist 27 (7) (2022)
Naifa L Busaidy, Bhavana Konda, Lai Wei, Lori J Wirth, Catherine Devine, Gregory A Daniels, Jonas A DeSouza, Ming Poi, Nathan D Seligson, Maria E Cabanillas, Jennifer A Sipos, Matthew D Ringel, Ann-Kathrin Eisfeld, Cynthia Timmers, Manisha H Shah
Dabrafenib Versus Dabrafenib + Trametinib in <i>BRAF</i>-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial. Thyroid : official journal of the American Thyroid Association 32 (10) (2022)
Alan L Ho, Marek Dedecjus, Lori J Wirth, R Michael Tuttle, William B Inabnet, Jan Tennvall, Fernanda Vaisman, Lars Bastholt, Andrew G Gianoukakis, Patrice Rodien, Ralf Paschke, Rossella Elisei, David Viola, Karen So, Danielle Carroll, Tina Hovey, Bhavana Thakre, James A Fagin, null null
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Hannah Lee, Vimal Krishnan, Lori J Wirth, Carmelo Nucera, Mariza Venturina, Peter M Sadow, Alain Mita, Wendy Sacks
Case Report of CCDC149-ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma. Thyroid : official journal of the American Thyroid Association (2022)
Connor J O'Boyle, Giulia Siravegna, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Kim Chang Sing Pang, Jarrod Stein, Julia C Thierauf, Peter M Sadow, William C Faquin, Wei Wang, Daniel G Deschler, Kevin S Emerick, Mark A Varvares, Jong Chul Park, John R Clark, Annie W Chan, Paul M Busse, Ryan B Corcoran, Lori J Wirth, Derrick T Lin, A John Iafrate, Jeremy D Richmon, Daniel L Faden
Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer. Cancer 128 (11) (2022)
Edwin Choy, Gregory M Cote, M Dror Michaelson, Lori J Wirth, Justin F Gainor, Alona Muzikansky, Lecia V Sequist, Ryan J Sullivan, Panagiotis M Fidias, Alice Shaw, Rebecca S Heist
Phase II Study of Cabozantinib in Patients With Bone Metastasis. The oncologist 27 (7) (2022)
Dora Dias-Santagata, Rebecca S Heist, Adam Z Bard, Annacarolina F L da Silva, Ibiayi Dagogo-Jack, Valentina Nardi, Lauren L Ritterhouse, Laura M Spring, Nicholas Jessop, Alexander A Farahani, Mari Mino-Kenudson, Jill Allen, Lipika Goyal, Aparna Parikh, Joseph Misdraji, Ganesh Shankar, Justin T Jordan, Maria Martinez-Lage, Matthew Frosch, Timothy Graubert, Amir T Fathi, Gabriela S Hobbs, Robert P Hasserjian, Noopur Raje, Jeremy Abramson, Joel H Schwartz, Ryan J Sullivan, David Michael Miller, Mai P Hoang, Steven Isakoff, Amy Ly, Sara Bouberhan, Jaclyn Watkins, Esther Oliva, Lori J Wirth, Peter M Sadow, William Faquin, Gregory M Cote, Yin P Hung, Xin Gao, Chin-Lee Wu, Salil Garg, Miguel Rivera, Long P Le, A John Iafrate, Dejan Juric, Ephraim P Hochberg, Jeffrey Clark, Aditya Bardia, Jochen K Lennerz
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network. The oncologist 27 (11) (2022)
Mimi I Hu, Steven G Waguespack, Chrysoula Dosiou, Paul W Ladenson, Masha J Livhits, Lori J Wirth, Peter M Sadow, Jeffrey F Krane, Brendan C Stack, Mark E Zafereo, Syed Z Ali, Steven P Weitzman, Yangyang Hao, Joshua E Babiarz, Giulia C Kennedy, Richard T Kloos
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules. The Journal of clinical endocrinology and metabolism 106 (8) (2021)
Lori J Wirth, Marcia S Brose, Eric J Sherman, Lisa F Licitra, Martin Schlumberger, Steven I Sherman, Keith C Bible, Bruce Robinson, Patrice Rodien, Yann Godbert, Christelle De La Fouchardière, Kate Newbold, Christopher Nutting, Soamnauth Misir, Ran Xie, Ana Almonte, Weifei Ye, Maria E Cabanillas
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Carrie C Lubitz, Peter M Sadow, Gilbert H Daniels, Lori J Wirth
Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy. Thyroid : official journal of the American Thyroid Association 31 (10) (2021)
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlesi, John C Morris, Taofeek K Owonikoko, Daniel S W Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E Burkard, Janessa Laskin, Matthew H Taylor, Matthias Kroiss, Jacques Medioni, Jonathan W Goldman, Todd M Bauer, Benjamin Levy, Viola W Zhu, Nehal Lakhani, Victor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H Shah, Maria E Cabanillas
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. The New England journal of medicine 383 (9) (2020)
Lori J Wirth, Makoto Tahara, Bruce Robinson, Sanjeev Francis, Marcia S Brose, Mouhammed Amir Habra, Kate Newbold, Naomi Kiyota, Corina E Dutcus, Elton Mathias, Matthew Guo, Steven I Sherman, Martin Schlumberger
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT). Cancer 124 (11) (2018)